Treatment with an OGA inhibitor in ALS mice significantly alleviates motor neuron death and ROS accumulation, indicating that decreased O‐GlcNAcylation impairs NPGPx function and exacerbates oxidative stress and neuronal death [204]. This evidence concerns the gene OGA and amyotrophic lateral sclerosis.